1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 5/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
1 vote

Topics under Therapy

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

Share
24/7 Customer Support

Talk to Sam

+1 718 473 0872

1-10 of about 29 000 reports

Global Therapy Market and Breast Cancer Statistics

  • September 2016
    25 pages
  • Therapy  

    Breast Cancer  

    Musculoskeletal...  

  • World  

    Europe  

    United States  

View report >

Therapy Market in the US

  • September 2016
    7 pages
  • Therapy  

  • United States  

View report >

Therapy Market and Targeted Therapy Market in the UK and Europe

  • September 2016
    13 pages
  • Therapy  

    Targeted Therap...  

  • United Kingdom  

    Europe  

View report >

Blood Disease Statistics and Therapy Market in Asia and Canada

  • July 2016
    67 pages
  • Blood Disease  

    Therapy  

    Blood Supply  

  • Asia  

    Canada  

View report >

Therapy Market in Japan

  • July 2016
    8 pages
  • Therapy  

  • Japan  

View report >

Therapy and Antiplatelet Market in Europe and France

  • August 2016
    8 pages
  • Therapy  

    Antiplatelet  

View report >

Therapy Market in Germany

  • July 2016
    9 pages
  • Therapy  

    Therapy  

    Anti Rheumatic  

  • Germany  

View report >

Therapy Market in Italy

  • September 2016
    11 pages
  • Targeted Therap...  

  • Italy  

View report >

Therapy Market in the UK

  • September 2016
    11 pages
  • Cancer Hormonal...  

  • United Kingdom  

View report >

Therapy Market in Canada

  • September 2016
    12 pages
  • Therapy  

  • Canada  

View report >


About 14 000 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 99 - $ 23 500)

2016 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

2016 Clinical Chemistry and Immunodiagnostic Analyzers and Reagents: Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies

  • $ 23 500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $37,500.  DataPack (test volumes, sales forecasts, supplier shares) $23,500. VPGMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities ...

Future Horizons And Growth Strategies In The World Clin ...

August 2016 $ 23 500

Global Clinical Chemistry And Immunodiagnostics Market ...

July 2016 $ 23 500

World Clinical Chemistry And Immunodiagnostic Markets: ...

July 2016 $ 23 500

World Cancer Diagnostics Market Future Horizons And Gro ...

August 2016 $ 21 100

Poc/point-of-care Diagnostic Testing Market New Frontie ...

July 2016 $ 16 600

Immunodiagnostics: Spot Fast-growing Market Segments--t ...

August 2016 $ 15 900

Clinical Chemistry And Immunodiagnostics: A Market In T ...

August 2016 $ 15 900

2016 Europe Clinical Chemistry And Immunodiagnostic Ana ...

September 2016 $ 12 800

Future Horizons And Growth Strategies In The European C ...

August 2016 $ 12 800

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.